[Analysis of clinical characteristics and prognosis of 235 pancreatic neuroendocrine tumors underwent Sunitinib treatment].

Xu, J M; Cui, H T; Jia, R; Zhao, C H; Zhao, P

Xu, J M; Cui, H T; Jia, R; Zhao, C H; Zhao, P.

Afiliação

Xu JM; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
Cui HT; Department of Oncology, the 940 Hospital of Joint Service of People's Liberation Army, Lanzhou 730050, China.
Jia R; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
Zhao CH; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
Zhao P; Cancer Foundation of China, Beijing 100021, China.

Zhonghua Zhong Liu Za Zhi ; 43(3): 324-328, 2021 Mar 23.

Article em Zh | MEDLINE | ID: mdl-33752313

Assuntos

Tumores Neuroendócrinos; Neoplasias Pancreáticas; Pré-Escolar; China/epidemiologia; Humanos; Tumores Neuroendócrinos/tratamento farmacológico; Tumores Neuroendócrinos/cirurgia; Neoplasias Pancreáticas/tratamento farmacológico; Neoplasias Pancreáticas/cirurgia; Prognóstico; Estudos Retrospectivos; Sunitinibe/uso terapêutico

Palavras-chave

Clinical characteristics; Pancreatic neuroendocrine tumors; Prognosis; Sunitinib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Tumores Neuroendócrinos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Child, preschool / Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google